Improve brain tumor radiation planning with high-resolution MR spectroscopy
Official title: Improving Image-Guided Radiation Therapy of Gliomas with High-Resolution MR Spectroscopic Imaging
Funded at Yale University · NIH-11360705 · Data updated 2026-11-12
Aims to use advanced MR spectroscopy imaging to more precisely target glioma tumors during radiation therapy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | September 30, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $464,213 |
| NIH project number | 5R01EB033582-05 |
| Project ID | NIH-11360705 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with newly diagnosed glioma undergoing radiation therapy.
✕Less likely to help
Patients not eligible for MR spectroscopy-guided planning or without glioma may not benefit.
What this research studies
This project at Yale University explores how high-resolution MR spectroscopic imaging can improve delineation of glioma boundaries to guide radiation therapy. By combining metabolic information from MRSI with standard MRI, clinicians may better define tumor edges and reduce damage to healthy brain tissue. The study builds on prior phase I results showing promise for dose-escalation strategies guided by metabolic imaging. Researchers will develop imaging protocols, correlate imaging findings with pathological data, and evaluate how these insights could refine treatment planning. The goal is to translate improved imaging accuracy into more effective and safer radiation treatment for glioma patients.
Why it matters
Potential benefit: If successful, patients could receive more precisely targeted radiation, potentially improving tumor control and reducing side effects.
How similar studies have gone: Previous early-phase work suggests that MRSI-guided planning can improve targeting, but larger validation is needed.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Ma, Chao — Yale University
- Study coordinator: Ma, Chao
Related research
Other NIH-funded projects on the same topics.
-
Protecting small blood vessels from radiation by boosting mitochondrial health
It aims to prevent radiation-related damage to tiny blood vessels and reduce later thinking and memory problems in people who get radiation therapy by protecting cell mitochondria.
-
Proton SBRT for refractory ventricular tachycardia with real-time 3D/4D imaging
A patient-facing study exploring a proton-based, noninvasive radiation therapy to treat stubborn VT using advanced 3D and 4D imaging to target the heart safely.
-
Embedding symptom support in radiation therapy for prostate cancer
A multi-site study tests whether delivering mindfulness-based symptom support right inside radiation therapy is feasible and acceptable for men with prostate cancer.
-
Targeting SREBP2 to boost radiation therapy in HPV-negative head and neck cancer
This grant aims to see if blocking SREBP2 can make radiation therapy work better for people with HPV-negative Head and Neck Squamous Cell Carcinoma.
-
Genetic and Immune Factors in Squaring the Room: Sacituzumab plus Radiation for Bladder Cancer
A study aims to understand why combining sacituzumab with radiation helps some bladder cancer patients more than others, with the goal of making bladder-sparing therapy more effective.
-
CivaDerm: a new four-day skin cancer radiation bandage
A new four‑day radiation bandage for non-melanoma skin cancer aims to treat facial and other areas without multiple clinic visits or big scars.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.